Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Drugs and Chemicals›Acrylamide
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Acrylamide

Drugs and Chemicals · NLM MeSH · updated 2026-10-31 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 5 min read

A colorless, odorless, highly water soluble vinyl monomer formed from the hydration of acrylonitrile.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (871 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

A colorless, odorless, highly water soluble vinyl monomer formed from the hydration of acrylonitrile. It is primarily used in research laboratories for electrophoresis, chromatography, and electron microscopy and in the sewage and wastewater treatment industries.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Where it fits in the MeSH classification

Broader topics
Acrylamides

Research landscape

PubMed indexes 4,043 records tagged with the MeSH heading “Acrylamide” (counts retrieved 2026-10-31). 1,149 of them (28.4%) were published from 2020 onward, and the busiest period so far is 2010-2019 with 1,233 records.

Reviews account for 260 records (6.4%) and meta-analyses for 9. Randomized controlled trials number 4 (0.1%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 640 records; 2000-2009: 1,021 records; 2010-2019: 1,233 records; 2020 onward: 1,149 records640through 19991,0212000-20091,2332010-20191,1492020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 1999640
2000-20091,021
2010-20191,233
2020 onward1,149
Share of records by publication typeReviews: 6.4 percent; Meta-analyses: 0.2 percent; Randomized controlled trials: 0.1 percentReviews6.4% (260)Meta-analyses0.2% (9)Randomized controlled trials0.1% (4)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 4,043 PubMed records
TypeRecordsShare
Reviews2606.4%
Meta-analyses90.2%
Randomized controlled trials40.1%

Method: PubMed query "Acrylamide"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-31.

Reading the evidence in drugs and chemicals

Studies of a chemical or drug can answer very different questions: what it is and how it behaves in cells and animals, how the body handles it, and whether it changes outcomes in people. Laboratory and animal findings often do not carry over to patients, and observational studies of exposures are confounded by who uses a substance and why. Nothing on this page is a recommendation to use, avoid, start or stop any substance or medicine; talk to a qualified clinician or pharmacist about your own situation. Check the dose, the species, the comparison group and whether a patient-relevant outcome was measured.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Molecular mechanism of acrylamide neurotoxicity: lessons learned from organic chemistry
LoPachin RM, Gavin T
2012Review article
Design not recorded in structured metadata
143cc0
PMID 23060388 · DOI · PMC3548275
Acrylamide acute neurotoxicity in adult zebrafish
Faria M, Ziv T, Gómez-Canela C, Ben-Lulu S, Prats E, Novoa-Luna KA, et al.
2018Research article
Design not recorded in structured metadata
80cc by
PMID 29784925 · DOI · PMC5962567
The anti-apoptotic, antioxidant and anti-inflammatory effects of curcumin on acrylamide-induced neurotoxicity in rats
Guo J, Cao X, Hu X, Li S, Wang J
2020Research article
Design not recorded in structured metadata
61cc by
PMID 32811563 · DOI · PMC7437006
Chemoselective Stabilized Triphenylphosphonium Probes for Capturing Reactive Carbonyl Species and Regenerating Covalent Inhibitors with Acrylamide Warheads in Cellulo
Chen AL, Lin ZJ, Chang HY, Wang TA
2025Research article
Design not recorded in structured metadata
8cc by
PMID 39730301 · DOI · PMC11744745

Molecular mechanism of acrylamide neurotoxicity: lessons learned from organic chemistry [1]

Review article LoPachin RM, Gavin T · · 2012 · cited 143 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundAcrylamide (ACR) produces cumulative neurotoxicity in exposed humans and laboratory animals through a direct inhibitory effect on presynaptic function.
Closing excerpt
The approach delineated here can be broadly applied because many toxicants of different chemical classes are electrophiles that produce toxicity by interacting with cellular proteins.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (246 words)

BackgroundAcrylamide (ACR) produces cumulative neurotoxicity in exposed humans and laboratory animals through a direct inhibitory effect on presynaptic function.ObjectivesIn this review, we delineate how knowledge of chemistry provided an unprecedented understanding of the ACR neurotoxic mechanism. We also show how application of the hard and soft, acids and bases (HSAB) theory led to the recognition that the α,β-unsaturated carbonyl structure of ACR is a soft electrophile that preferentially forms covalent bonds with soft nucleophiles.MethodsIn vivo proteomic and in chemico studies demonstrated that ACR formed covalent adducts with highly nucleophilic cysteine thiolate groups located within active sites of presynaptic proteins. Additional research showed that resulting protein inactivation disrupted nerve terminal processes and impaired neurotransmission.DiscussionACR is a type-2 alkene, a chemical class that includes structurally related electrophilic environmental pollutants (e.g., acrolein) and endogenous mediators of cellular oxidative stress (e.g., 4-hydroxy-2-nonenal). Members of this chemical family produce toxicity via a common molecular mechanism. Although individual environmental concentrations might not be toxicologically relevant, exposure to an ambient mixture of type-2 alkene pollutants could pose a significant risk to human health. Furthermore, environmentally derived type-2 alkenes might act synergistically with endogenously generated unsaturated aldehydes to amplify cellular damage and thereby accelerate human disease/injury processes that involve oxidative stress.ConclusionsThese possibilities have substantial implications for environmental risk assessment and were realized through an understanding of ACR adduct chemistry. The approach delineated here can be broadly applied because many toxicants of different chemical classes are electrophiles that produce toxicity by interacting with cellular proteins.

Abstract reproduced from the open-access article under the recorded cc0 licence; © the authors. PMID 23060388 · DOI · PMC3548275

Acrylamide acute neurotoxicity in adult zebrafish [2]

Research article Faria M, Ziv T, Gómez-Canela C, Ben-Lulu S, Prats E, Novoa-Luna KA, et al. · · 2018 · cited 80 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Acute exposure to acrylamide (ACR), a type-2 alkene, may lead to a ataxia, skeletal muscles weakness and numbness of the extremities in human and laboratory animals.
Closing excerpt
Finally, the metabolomics analysis shows a depletion in the monoamine neurotransmitters, consistent with the comorbid depression and anxiety disorder, in the brain of the exposed fish.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (144 words)

Acute exposure to acrylamide (ACR), a type-2 alkene, may lead to a ataxia, skeletal muscles weakness and numbness of the extremities in human and laboratory animals. In the present manuscript, ACR acute neurotoxicity has been characterized in adult zebrafish, a vertebrate model increasingly used in human neuropharmacology and toxicology research. At behavioral level, ACR-treated animals exhibited "depression-like" phenotype comorbid with anxiety behavior. At transcriptional level, ACR induced down-regulation of regeneration-associated genes and up-regulation of oligodendrocytes and reactive astrocytes markers, altering also the expression of genes involved in the presynaptic vesicle cycling. ACR induced also significant changes in zebrafish brain proteome and formed adducts with selected cysteine residues of specific proteins, some of them essential for the presynaptic function. Finally, the metabolomics analysis shows a depletion in the monoamine neurotransmitters, consistent with the comorbid depression and anxiety disorder, in the brain of the exposed fish.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 29784925 · DOI · PMC5962567

The anti-apoptotic, antioxidant and anti-inflammatory effects of curcumin on acrylamide-induced neurotoxicity in rats [3]

Research article Guo J, Cao X, Hu X, Li S, Wang J · · 2020 · cited 61 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundAcrylamide (ACR) formed during heating of tobacco and carbohydrate-rich food as well as widely applied in industries has been known as a well-established neurotoxic pollutant.
Closing excerpt
Maintaining TERT-related anti-apoptotic function might be one mechanism underlying the protective effect of curcumin on ACR-intoxicated brains.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (343 words)

BackgroundAcrylamide (ACR) formed during heating of tobacco and carbohydrate-rich food as well as widely applied in industries has been known as a well-established neurotoxic pollutant. Although the precise mechanism is unclear, enhanced apoptosis, oxidative stress and inflammation have been demonstrated to contribute to the ACR-induced neurotoxicity. In this study, we assessed the possible anti-apoptotic, antioxidant and anti-inflammatory effects of curcumin, the most active component in a popular spice known as turmeric, on the neurotoxicity caused by ACR in rats.MethodsCurcumin at the dose of 50 and 100 mg/kg was orally given to ACR- intoxicated Sprague-Dawley rats exposed by ACR at 40 mg/kg for 4 weeks. All rats were subjected to behavioral analysis. The HE staining and terminal deoxynucleotidyl transferase mediated dUTP nick end labelling (TUNEL) staining were used to detect histopathological changes and apoptotic cells, respectively. The mRNA and protein expressions of apoptosis-related molecule telomerase reverse transcriptase (TERT) were detected using real-time PCR and immunohistochemistry, respectively. The contents of malondialdehyde (MDA) and glutathione (GSH) as well as the activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) were measured as the indicators for evaluating the level of oxidative stress in brain. The levels of pro-inflammatory cytokinestumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in the cerebral homogenates were detected using ELISA assay.ResultsACR-induced weigh loss, deficits in motor function as well as pathological alterations in brains were significantly improved in rats administrated with 50 and 100 mg/kg curcumin. TUNEL-positive apoptotic cells in curcumin-treated ACR intoxicated brains were less than those in the ACR model group. Curcumin administration especially at the dose of 100 mg/kg upregulated the TERT mRNA expression and enhanced the number of TERT-positive cells in ACR-intoxicated cortex tissues. Moreover, curcumin treatment reduced the concentrations of TNF-α, IL-1β and MDA, while increased the GSH contents as well as the SOD and GSH-Px activities in the cerebral homogenates, in comparison to ACR control group.ConclusionsThese data suggested the anti-apoptotic, antioxidant and anti-inflammatory effects of curcumin on ACR-induced neurotoxicity in rats. Maintaining TERT-related anti-apoptotic function might be one mechanism underlying the protective effect of curcumin on ACR-intoxicated brains.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 32811563 · DOI · PMC7437006

Chemoselective Stabilized Triphenylphosphonium Probes for Capturing Reactive Carbonyl Species and Regenerating Covalent Inhibitors with Acrylamide Warheads in Cellulo [4]

Research article Chen AL, Lin ZJ, Chang HY, Wang TA · · 2025 · cited 8 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Reactive carbonyl species (RCS) are important biomarkers of oxidative stress-related diseases because of their highly reactive electrophilic nature.
Closing excerpt
These structural variations influence their protein binding profiles and consequently alter their cytotoxicity, which is beneficial for the development of inhibitor cocktails.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (138 words)

Reactive carbonyl species (RCS) are important biomarkers of oxidative stress-related diseases because of their highly reactive electrophilic nature. Despite their potential as triggers for prodrug activation, selective labeling approaches for RCS remain limited. Here, we utilized triphenylphosphonium groups to chemoselectively capture RCS via an aqueous Wittig reaction, forming α,β-unsaturated carbonyls that enable further functionalization. We first designed native (light) and deuterated (heavy) probes to facilitate RCS metabolomic identification through distinct MS isotope patterns. This approach allowed us to capture and relatively quantify several endogenous RCS related to advanced lipoxidation/glycation end products (ALEs/AGEs). Second, we demonstrated that various endogenous RCS can trigger the in situ generation of acrylamide warheads of targeted covalent inhibitors (TCIs) with different substituents. These structural variations influence their protein binding profiles and consequently alter their cytotoxicity, which is beneficial for the development of inhibitor cocktails.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 39730301 · DOI · PMC11744745

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Chemistry, biochemistry, and safety of acrylamide. A review [5]
    Friedman M · J Agric Food Chem · 2003 · cited 635 times (Europe PMC)
  • Research article Human exposure and internal dose assessments of acrylamide in food [6]
    Dybing E, Farmer PB, Andersen M, Fennell TR, Lalljie SP, Müller DJ, et al. · Food Chem Toxicol · 2005 · cited 237 times (Europe PMC)
  • Research article A review of acrylamide: an industry perspective on research, analysis, formation, and control [7]
    Taeymans D, Wood J, Ashby P, Blank I, Studer A, Stadler RH, et al. · Crit Rev Food Sci Nutr · 2004 · cited 226 times (Europe PMC)
  • Research article The carcinogenicity of acrylamide [8]
    Rice JM · Mutat Res · 2005 · cited 180 times (Europe PMC)
  • Research article Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects [9]
    Shipp A, Lawrence G, Gentry R, McDonald T, Bartow H, Bounds J, et al. · Crit Rev Toxicol · 2006 · cited 176 times (Europe PMC)
  • Research article A Review on Acrylamide in Food: Occurrence, Toxicity, and Mitigation Strategies [10]
    Rifai L, Saleh FA · Int J Toxicol · 2020 · cited 159 times (Europe PMC)

References

  1. LoPachin RM, Gavin T. Molecular mechanism of acrylamide neurotoxicity: lessons learned from organic chemistry. . 2012. PMID 23060388 · DOI · PMC3548275
  2. Faria M, Ziv T, Gómez-Canela C, Ben-Lulu S, Prats E, Novoa-Luna KA, et al.. Acrylamide acute neurotoxicity in adult zebrafish. . 2018. PMID 29784925 · DOI · PMC5962567
  3. Guo J, Cao X, Hu X, Li S, Wang J. The anti-apoptotic, antioxidant and anti-inflammatory effects of curcumin on acrylamide-induced neurotoxicity in rats. . 2020. PMID 32811563 · DOI · PMC7437006
  4. Chen AL, Lin ZJ, Chang HY, Wang TA. Chemoselective Stabilized Triphenylphosphonium Probes for Capturing Reactive Carbonyl Species and Regenerating Covalent Inhibitors with Acrylamide Warheads in Cellulo. . 2025. PMID 39730301 · DOI · PMC11744745
  5. Friedman M. Chemistry, biochemistry, and safety of acrylamide. A review. J Agric Food Chem. 2003. PMID 14705871 · DOI
  6. Dybing E, Farmer PB, Andersen M, Fennell TR, Lalljie SP, Müller DJ, et al.. Human exposure and internal dose assessments of acrylamide in food. Food Chem Toxicol. 2005. PMID 15680675 · DOI
  7. Taeymans D, Wood J, Ashby P, Blank I, Studer A, Stadler RH, et al.. A review of acrylamide: an industry perspective on research, analysis, formation, and control. Crit Rev Food Sci Nutr. 2004. PMID 15540646 · DOI
  8. Rice JM. The carcinogenicity of acrylamide. Mutat Res. 2005. PMID 15668103 · DOI
  9. Shipp A, Lawrence G, Gentry R, McDonald T, Bartow H, Bounds J, et al.. Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects. Crit Rev Toxicol. 2006. PMID 16973444 · DOI
  10. Rifai L, Saleh FA. A Review on Acrylamide in Food: Occurrence, Toxicity, and Mitigation Strategies. Int J Toxicol. 2020. PMID 32013673 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-31.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • 2-AcetylaminofluoreneDrugs and Chemicals
  • AcetatesDrugs and Chemicals
  • Acetic AcidDrugs and Chemicals
  • Butyric AcidDrugs and Chemicals
  • LevetiracetamDrugs and Chemicals
  • LinezolidDrugs and Chemicals

All 546 articles in Drugs and Chemicals →

At a glance

4,043
PubMed records on this heading
28%
published since 2020
260
review articles
4
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-31; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • 2-AcetylaminofluoreneDrugs and Chemicals
  • AcetatesDrugs and Chemicals
  • Acetic AcidDrugs and Chemicals
  • Butyric AcidDrugs and Chemicals
  • LevetiracetamDrugs and Chemicals

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support